Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biophase equilibration times.

P Veng-Pedersen1, J W Mandema, M Danhof

  • 1University of Iowa, College of Pharmacy, Iowa City.

Journal of Pharmaceutical Sciences
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: "Simultaneous Pharmacokinetic Modeling of Gentamicin, Tobramycin and Vancomycin Clearance From Neonates to Adults: Towards a Semi-physiological Function for Maturation in Glomerular Filtration".

Pharmaceutical research·2025
Same author

Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.

European journal of clinical pharmacology·2017
Same author

Direct Oral Anticoagulants Vs. Enoxaparin for Prevention of Venous Thromboembolism Following Orthopedic Surgery: A Dose-Response Meta-analysis.

Clinical and translational science·2017
Same author

Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women.

CPT: pharmacometrics & systems pharmacology·2016
Same author

Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration.

CPT: pharmacometrics & systems pharmacology·2016
Same author

Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studies.

British journal of pharmacology·2016

This study introduces Biophase Equilibration Time (BET) and Biophase Equilibration Profiles (BEPs) to measure how fast drugs reach their target site. These metrics aid in optimizing drug delivery and design.

Area of Science:

  • Pharmacology
  • Pharmacokinetics
  • Systems Biology

Background:

  • Accurate characterization of drug disposition kinetics is crucial for effective therapeutic strategies.
  • Understanding the dynamic behavior of drug concentrations at the biophase is essential for predicting drug response.
  • Existing methods may not fully capture the rate of drug equilibration at the site of action.

Purpose of the Study:

  • To propose and define Biophase Equilibration Time (BET) and Biophase Equilibration Profiles (BEPs) as quantitative measures of drug equilibration rate.
  • To introduce a pharmacodynamic system analysis method for determining BETs and BEPs.
  • To explore the application of BET and BEP principles in optimizing drug administration and design.

Main Methods:

  • Definition of BET as the time to reach a specific percentage (p) of steady-state biophase drug concentration.

Related Experiment Videos

  • Development of BEPs by plotting percentage (p) versus BET.
  • Application of a pharmacodynamic system analysis method using biophase conduction function.
  • Demonstration using amobarbital's central nervous system effects via EEG analysis.

    • Main Results:

    • BET provides a quantitative measure for the speed of drug equilibration at the biophase.
    • BEPs offer a dynamic representation of the approach to equilibrium.
    • The proposed method successfully determined BETs and BEPs from experimental data.
    • The analysis considered both vascular and extravascular drug administration routes.

    Conclusions:

    • BET and BEPs are valuable metrics for assessing drug delivery rates to the biophase.
    • These principles can inform optimal computer-controlled drug infusion strategies.
    • BET and BEP analysis may enhance drug design and the evaluation of targeted drug delivery systems.